by Kelly Springer A new report shows that more than 15.5 million people have used GLP-1 (glucagon-like peptide-1) receptor agonists like Semaglutide for weight loss. With summer […]
Tag: obesity drugs
Fears about ‘Ozempic babies’ show how woeful women’s health care is
by Mary McNamara The historic failure of medical research to acknowledge that women’s bodies differ from men’s has a new catchphrase: Ozempic babies. According to recent reports, […]
Guest essay: PEIA should cover obesity meds
by Mollie McCartney Cecil On Feb. 28, PEIA announced that it was going to stop coverage of anti-obesity medications effective March 15. This includes both pill and […]
What got lost in obesity drug hype
by Lisa Jarvis This year, the incredible potential of obesity medicines like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound started to come into view. The […]
New weight loss drugs are promising — and expensive
West Virginia has a weight problem. Forty-one percent of state residents are clinically obese, which is defined as having a body mass index (BMI) of greater than […]
Guest essay: It’s time for Medicare to cover anti-obesity medications
by Sabrina Weekley For many West Virginians, food means family. We grew up with our grandmothers fixing big meals as an expression of their love. And in […]
Obesity drugs can’t work if they aren’t affordable
More than 40% of American adults are obese, costing the health care system $173 billion a year. Related conditions, including heart disease, stroke, type 2 diabetes and […]
